RS60508B1 - Farmaceutska kompozicija za lečenje mikoza - Google Patents
Farmaceutska kompozicija za lečenje mikozaInfo
- Publication number
- RS60508B1 RS60508B1 RS20200615A RSP20200615A RS60508B1 RS 60508 B1 RS60508 B1 RS 60508B1 RS 20200615 A RS20200615 A RS 20200615A RS P20200615 A RSP20200615 A RS P20200615A RS 60508 B1 RS60508 B1 RS 60508B1
- Authority
- RS
- Serbia
- Prior art keywords
- mycosis
- treatment
- pharmaceutical composition
- pharmaceutical
- composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A61K31/416—1,2-Diazoles condensed with carbocyclic ring systems, e.g. indazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4174—Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4196—1,2,4-Triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP15150904 | 2015-01-13 | ||
| PCT/EP2016/050272 WO2016113194A1 (en) | 2015-01-13 | 2016-01-08 | Pharmaceutical composition for the treatment of mycosis |
| EP16700189.0A EP3244889B1 (en) | 2015-01-13 | 2016-01-08 | Pharmaceutical composition for the treatment of mycosis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| RS60508B1 true RS60508B1 (sr) | 2020-08-31 |
Family
ID=52396443
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RS20200615A RS60508B1 (sr) | 2015-01-13 | 2016-01-08 | Farmaceutska kompozicija za lečenje mikoza |
Country Status (29)
| Country | Link |
|---|---|
| US (1) | US9962372B2 (sr) |
| EP (1) | EP3244889B1 (sr) |
| JP (1) | JP6714597B2 (sr) |
| KR (1) | KR102606081B1 (sr) |
| CN (1) | CN107106690B (sr) |
| AR (1) | AR103381A1 (sr) |
| AU (1) | AU2016208200B2 (sr) |
| BR (1) | BR112017014295B1 (sr) |
| CA (1) | CA2970060C (sr) |
| CY (1) | CY1122979T1 (sr) |
| DK (1) | DK3244889T3 (sr) |
| EA (1) | EA035748B1 (sr) |
| ES (1) | ES2794824T3 (sr) |
| GE (1) | GEP20196962B (sr) |
| HK (1) | HK1246146A1 (sr) |
| HR (1) | HRP20200815T1 (sr) |
| HU (1) | HUE049877T2 (sr) |
| IL (1) | IL252774A0 (sr) |
| LT (1) | LT3244889T (sr) |
| MD (1) | MD3244889T2 (sr) |
| ME (1) | ME03736B (sr) |
| MX (1) | MX2017008879A (sr) |
| PL (1) | PL3244889T3 (sr) |
| PT (1) | PT3244889T (sr) |
| RS (1) | RS60508B1 (sr) |
| SG (1) | SG11201704964RA (sr) |
| SI (1) | SI3244889T1 (sr) |
| UA (1) | UA120864C2 (sr) |
| WO (1) | WO2016113194A1 (sr) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109562058A (zh) | 2016-07-08 | 2019-04-02 | 方济各安吉利克化学联合股份有限公司 | 包含苄达明的药物组合物 |
| CN112514904B (zh) * | 2021-01-26 | 2021-10-26 | 青岛农业大学 | 盐酸苄达明在制备用于防治由植物病原菌引起的植物病害的杀菌剂中的应用 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9224598D0 (en) | 1992-11-24 | 1993-01-13 | Smithkline Beecham Plc | Novel compositions |
| IT1274655B (it) * | 1995-02-28 | 1997-07-18 | Smithkline Beecham Farma | Composizioni farmaceutiche contenenti un agente antiinfiammatorio e un agente antimicrobico |
| US6913759B2 (en) * | 2003-03-11 | 2005-07-05 | Curatek Pharmaceuticals Holding, Inc. | Gel composition and method for treatment of vaginal infections |
| CA2651726C (en) | 2006-05-12 | 2015-12-15 | Pharmacon - Forschung Und Beratung Gmbh | Use of combination preparations, comprising antimycotics |
| CN1887352A (zh) * | 2006-07-13 | 2007-01-03 | 徐艳 | 治疗眼部真菌和细菌感染的组合物 |
| GB201000196D0 (en) * | 2010-01-07 | 2010-02-24 | Galvez Julian M | Novel combination |
-
2016
- 2016-01-08 ES ES16700189T patent/ES2794824T3/es active Active
- 2016-01-08 RS RS20200615A patent/RS60508B1/sr unknown
- 2016-01-08 ME MEP-2020-100A patent/ME03736B/me unknown
- 2016-01-08 CN CN201680004851.0A patent/CN107106690B/zh active Active
- 2016-01-08 MX MX2017008879A patent/MX2017008879A/es unknown
- 2016-01-08 BR BR112017014295-3A patent/BR112017014295B1/pt active IP Right Grant
- 2016-01-08 AU AU2016208200A patent/AU2016208200B2/en active Active
- 2016-01-08 CA CA2970060A patent/CA2970060C/en active Active
- 2016-01-08 JP JP2017535653A patent/JP6714597B2/ja active Active
- 2016-01-08 EP EP16700189.0A patent/EP3244889B1/en active Active
- 2016-01-08 DK DK16700189.0T patent/DK3244889T3/da active
- 2016-01-08 PT PT167001890T patent/PT3244889T/pt unknown
- 2016-01-08 SI SI201630773T patent/SI3244889T1/sl unknown
- 2016-01-08 MD MDE20170279T patent/MD3244889T2/ro unknown
- 2016-01-08 LT LTEP16700189.0T patent/LT3244889T/lt unknown
- 2016-01-08 EA EA201791483A patent/EA035748B1/ru unknown
- 2016-01-08 PL PL16700189T patent/PL3244889T3/pl unknown
- 2016-01-08 WO PCT/EP2016/050272 patent/WO2016113194A1/en active Application Filing
- 2016-01-08 GE GEAP201614557A patent/GEP20196962B/en unknown
- 2016-01-08 KR KR1020177019214A patent/KR102606081B1/ko active IP Right Grant
- 2016-01-08 HU HUE16700189A patent/HUE049877T2/hu unknown
- 2016-01-08 AR ARP160100043A patent/AR103381A1/es unknown
- 2016-01-08 SG SG11201704964RA patent/SG11201704964RA/en unknown
- 2016-01-08 UA UAA201705952A patent/UA120864C2/uk unknown
- 2016-01-08 US US15/541,245 patent/US9962372B2/en active Active
-
2017
- 2017-06-08 IL IL252774A patent/IL252774A0/en active IP Right Grant
-
2018
- 2018-04-24 HK HK18105346.0A patent/HK1246146A1/zh unknown
-
2020
- 2020-05-19 HR HRP20200815TT patent/HRP20200815T1/hr unknown
- 2020-06-02 CY CY20201100519T patent/CY1122979T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL290823A (en) | Pharmaceutical preparations for combination therapy | |
| IL268316B (en) | Pharmaceutical preparations for combined treatment | |
| IL265360A (en) | Pharmaceutical composition | |
| IL265260B (en) | pharmaceutical preparations | |
| IL262654A (en) | Pharmacy preparation | |
| IL265349A (en) | Pharmaceutical composition | |
| HUE046729T2 (hu) | Mirabegront tartalmazó gyógyszerkészítmény | |
| IL261278A (en) | Pharmaceutical compositions for the treatment of cancer | |
| IL263040A (en) | Pharmaceutical composition comprising eteplirsen | |
| GB201521462D0 (en) | Pharmaceutical composition | |
| GB201515310D0 (en) | Pharmaceutical composition | |
| PL3454838T3 (pl) | Kompozycja farmaceutyczna | |
| GB201615917D0 (en) | Pharmaceutical composition | |
| HK1246146A1 (zh) | 用於治療真菌病的藥物組合物 | |
| GB201520862D0 (en) | Pharmaceutical composition | |
| GB201615910D0 (en) | Pharmaceutical composition | |
| GB201615914D0 (en) | Pharmaceutical composition | |
| IL265436B (en) | Pharmacy preparation | |
| PL3424500T3 (pl) | Kompozycja farmaceutyczna zawierająca famitynib | |
| PL3164110T3 (pl) | Kompozycje farmaceutyczne do leczenia łuszczycy | |
| IL265428A (en) | Pharmaceutical composition | |
| PT3476391T (pt) | Composição farmacêutica que compreende arginina para utilização no tratamento da doença de poliq | |
| GB201714241D0 (en) | Pharmaceutical compositions for the treatment of proteinopathies | |
| GB201620519D0 (en) | Pharmaceutical composition | |
| GB201620515D0 (en) | Pharmaceutical composition |